| Document |
Document Title |
|
WO/2004/041774A1 |
An aromatic amine derivative represented by the following general formula (1); and an organic electroluminescent element which has at least one thin organic layer containing either the aromatic amine derivative alone or a mixture of the ...
|
|
WO/2004/039762A1 |
The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of...
|
|
WO/2004/037768A2 |
The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of...
|
|
WO/2004/035534A2 |
The invention relates to novel compounds of 4-[2-(4-arylpiperazin-1-yl)-ethoxy]benzo-1,2-diamine I, to the derivatives thereof in the form of benzoimidazole-2-thiones, benzoimidazoles and benzotriazoles, to the use of the pharmacological...
|
|
WO/2004/035521A1 |
Compounds of Formula (1), wherein R1 is hydrogen; C1-C18alkyl; trifluoromethyl; C3-C8cycloalkyl; phenyl-C1-C5alkyl; phenyl-C1-C5alkoxy; mono- or di-N-C1-C5alkylamino-C1-C5alkyl; amino-di-N-C1-C5alkylamino-C1-C5alkyl; C1-C5alkoxy-C1-C5alk...
|
|
WO/2004/033412A1 |
The invention relates to compounds of general formula (I), where the groups R1, R2 and R3 can have the meanings given in the claims and the description, method for production and use thereof as medicaments, in particular for the treatmen...
|
|
WO/2004/031125A1 |
Spiro compounds represented by the following general formula (I) or pharmaceutically acceptable acid-addition salts thereof: (I) wherein R1 and R2 are the same or different and each represents hydrogen, chlorine, etc.; n is 1, 2 or 3; a ...
|
|
WO/2004/028451A2 |
β-hydroxyphenylalkylamines and their use for lowering and controlling ocular hypertension and treating glaucoma are disclosed.
|
|
WO/2004/027788A1 |
A nonaqueous electrolyte comprising both an ionic fluid which is represented by the general formula (1) and takes a liquid form at 50°C or below and an ionically conductive polymer. This electrolyte brings about secondary cells and elec...
|
|
WO/2004/026817A1 |
An amino alcohol derivative represented by the general formula (1): (1) &lcub e.g., (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-
methylpentan-1-ol&rcub . It has excellent immunosuppressive activity and is reduced in side ...
|
|
WO/2004/026815A2 |
The present invention is related to a compound of the formula (I), (II), (III), (IV), (V): wherein Z1, Z2, Z3 and Z4 are each and independently selected from the group comprising C(O)-, -C(S)-, -C(O)-NR10-, -C(S)-NR11-, -C(N-CN)-NR12-, -...
|
|
WO/2004/026807A1 |
Intermediates represented by the following general formula (I), etc. which are useful in producing phenoxyacetic acid derivatives represented by the following general formula (X) or pharmaceutically acceptable salts thereof having an eff...
|
|
WO/2004/024672A1 |
The invention relates to (1S)-1-isobutoxymethyl-3- methylbutylamine useful as an intermediate in the synthesis of sodium (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl]- carbamoyl]oxirane-2-carboxylate and a process for production the...
|
|
WO/2004/024673A1 |
Compounds of formula (I) wherein R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
|
|
WO/2004/022521A1 |
An optically active 1-(fluoro-, trifluoromethyl- or trifluoromethoxy-substituted phenyl)alkylamine N-monoalkyl derivative represented by the formula [4] is produced by a process including (a) reacting an optically active secondary amine,...
|
|
WO/2004/020388A1 |
A novel monoamino compound is provided. Using the monoamino compound, an organic luminescence device is provided, which exhibits a luminescence hue with extremely high purity, and having an optical output of a high luminance with a high ...
|
|
WO/2004/020506A2 |
Provided herein are polyamine precursors useful in the manufacture of epoxy resins. Use of a polyamine precursor according to the invention provides an epoxy resin formulation having an increased working time over prior art amines used f...
|
|
WO/2004/021500A1 |
A nonaqueous electrolyte which comprises an ionic liquid represented by the following general formula (1) and having a melting point of 50°C or lower, a compound which is reductively decomposed at a nobler potential than the ionic liqui...
|
|
WO/2004/020390A1 |
The invention relates to a method for the production of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol with high stereoselectivity and in high yield.
|
|
WO/2004/020372A1 |
A fluorene compound represented by the following general formula [I]: is used to provide an organic luminescent device. Such a device has an optical output exhibiting a high luminance with an extremely high efficiency, and has an extreme...
|
|
WO/2004/016576A1 |
A compound represented by the general formula (I) [wherein ring A represents an optionally substituted 5- to 8-membered ring; ring B represents a further optionally substituted 4- to 10-membered ring; ring C represents a further optional...
|
|
WO/2004/016828A2 |
Alkoxylated compounds of formula (I) R((AO)nH)m Hp wherein each AO group is independently an alkyleneoxy group selected from ethyleneoxy, 1,2-propyleneoxy, 1,2-butyleneoxy, and styryleneoxy groups; n is an integer of from 2 to 100; m is ...
|
|
WO/2004/014551A2 |
An immobilised nitrogen-containing ligand is described comprising the reaction product of a compound of formula (I) wherein R5, R6, R7 and R8 are independently hydrogen, a saturated or unsaturated C1-C10 alkyl group, an aryl group, a ure...
|
|
WO/2004/014841A1 |
The present invention relates to anaesthetics and in particular to metabolites and derivatives of mexiletine such as compounds of formula (I); wherein R1 to R8 are as defined in the specification. It also relates to a prodrugs including ...
|
|
WO/2004/014682A1 |
A vehicle door has a supporting frame (10) substantially in the form of a rectangular annular hat beam (13-16) of high-strength steel, which, with its outer side flange (17), carries the outer panel (28) of the door and has its crown (12...
|
|
WO/2004/014550A2 |
The invention relates to novel monocarbene complexes of nickel, palladium or platinum containing electron-deficient olefin ligands, to their production and to the use thereof in the homogeneous catalysis of organic reactions (Formula II ...
|
|
WO/2004/013081A1 |
Process for the preparation of primary amines of formula (I): on enclosed where R3 represents an alkyl, cycloalkyl or aralkyl group, by reaction of a triazolium salt of formula (II): (formula see on enclosed paper version) where R1 and R...
|
|
WO/2004/013082A2 |
The invention relates to methods for producing 4-[aminoalkoxy]benzylamines of general formula (I) by means of catalytic hydrogenation of 4-[aminoalkoxy]benzonitriles of general formula (II). In the compounds of general formulae (I) and (...
|
|
WO/2004/011417A1 |
The invention relates to N-bisaryl- and N-aryl-cycloalkylidenyl-a-hydroxy- and a-alkoxy acetic acid amides of the general formula (I) including the optical isomers thereof and mixtures of such isomers, wherein R1 is hydrogen, C1-C12alkyl...
|
|
WO/2004/011400A1 |
A method of deuterating a compound having an aromatic ring in the presence of an activated catalyst. In particular, a method of deuterating a compound having an aromatic ring characterized in that a compound having an aromatic ring is re...
|
|
WO/2004/009552A1 |
PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula (I): wherein R1, R2 R 3 and R4 are as defined herein.
|
|
WO/2004/009529A1 |
Disclosed herein is a process for the reductive alkylation of primary amines to form secondary amines, by high pressure reaction of the primary amine with an alkylating agent and hydrogen in the presence of a catalyst which comprises met...
|
|
WO/2004/009067A1 |
The invention relates to metabolites of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine as free bases and/or in the form of physiologically acceptable salts, corresponding medicaments, the use of [2-(3-methoxyphenyl)-cyclohexylmethy...
|
|
WO/2004/009034A2 |
The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat ...
|
|
WO/2004/009531A1 |
This invention is directed to acetylenic compounds as inhibitors of a nicotinamide adenine dinucleotide oxidase hydride donor useful in treating or ameliorating a reactive oxygen species mediated inflammatory disorders.
|
|
WO/2004/007407A2 |
The present invention includes methods and compositions for increasing the fluorous nature of an organic compound by reacting it with at least one fluorous compound to produce a fluorous tagged organic compound. The increased fluorous na...
|
|
WO/2004/005406A2 |
The present invention relates to charge transport compositions. The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport compositions.
|
|
WO/2004/006355A2 |
The present invention relates to charge transport compositions containing a quinazoline derivative of formula I, II or III . The invention further relates to electronic devices in which there is at least one active layer comprising such ...
|
|
WO/2004/005288A2 |
The present invention relates to charge transport compositions comprising a compound of Formula (I). The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport composi...
|
|
WO/2004/006354A2 |
The present invention relates to polymeric charge transport compositions. The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport compositions.
|
|
WO/2004/005301A1 |
The invention relates to processes for preparing a compound of the formula (V) and alkyl boronic esters thereof wherein R1 is attached at the 2 or 3 position of the benzene ring, R2 is attached at the 5 or 6 position and R1, R2 and G are...
|
|
WO/2004/006352A2 |
The present invention is directed to a photoactive device comprising an anode, a cathode, and a photoactive layer, which device further comprises an electron transport and/or anti-quenching layer which minimizes both electron transfer qu...
|
|
WO/2004/002947A1 |
Compounds of formula (I), wherein R01 is hydrogen, C1-C8alkyl, C3-C8alkenyl or C3-C8alkynyl; or R01 is phenyl or phenyl-C1-C6alkyl, it being possible for the phenyl rings in turn to be mono- to penta-substituted by halogen and/or mono-, ...
|
|
WO/2004/002939A2 |
The present invention relates to a compound formula [I]: Y is bond, -0-(CH2)n- (in which n is 1, 2, 3 or 4), etc., Z is cyano, tetrazolyl, etc., R1 is hydrogen, lower alkyl, etc., R2 is hydrogen or an amino protective group, R3 is hydrog...
|
|
WO/2004/002943A1 |
Compounds of formula (I), wherein A1, A2 and A3 are each independently of the others a bond or a C1-C6alkylene bridge; A4 is a C1-C6alkylene bridge; Di s CH or N; W is, for example, O, NR7 or S; T is, for example, a bond, O, NH or NR7; Q...
|
|
WO/2004/000302A1 |
This invention relates to novel resveratrol analogs of the formula given below; wherein R, R¿1?, R¿2? and R¿3? are: 1. R=OH, R¿1?=R¿2?=R¿3?=H; 2. R=0H, R¿1?=Br, R¿2?=R¿3?=H; 3. R=R¿1?=0H, R¿2?=R¿3?=H; 4. R=R¿1?=R¿3?=H, R¿2...
|
|
WO/2004/000783A1 |
The present invention relates to Mannich base antimalarial aminoalkylphenol compounds and their use against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia. This invention further relates to co...
|
|
WO/2004/000762A2 |
A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, .Wherein:R1 and R2 are independently hydrogen or C1-3 alkyl;X represents a bond, CH2 or O;R3 and R4 are independently hydrogen, C1-6...
|
|
WO/2003/103609A2 |
Disclosed herein are trifluoromethylepinephrine compounds having the following structural formula (I) wherein R1-R5 are each independently selected from the group consisting of H, alkyl, alkoxyl, aryl, heteroaryl, cycloalkyl, heterocyclo...
|
|
WO/2003/103650A1 |
The invention relates to active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
, to methods for the production thereof, and to the...
|
